CVS vs ITRM · P/E 16, rev $402.07B vs rev $390.0K
CVS Health Corp (CVS) versus Iterum Therapeutics PLC (ITRM) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. ITRM currently screens at market cap $38.6M.
Not investment advice. Open the CVS and ITRM stock pages for the full models.
Not investment advice.